These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 9221302)

  • 1. [Drug therapy of ventricular arrhythmias].
    Hohnloser SH
    Med Klin (Munich); 1997 Apr; 92(4):208-10. PubMed ID: 9221302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacologic therapy of ventricular tachyarrhythmias: value of class III anti-arrhythmia drugs].
    Haverkamp W; Borggrefe M; Block M; Böcker D; Breithardt G
    Z Kardiol; 1996; 85 Suppl 6():97-106. PubMed ID: 9064989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From first class to third class: recent upheaval in antiarrhythmic therapy--lessons from clinical trials.
    Lazzara R
    Am J Cardiol; 1996 Aug; 78(4A):28-33. PubMed ID: 8780326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ventricular cardiac arrhythmias. New anti-arrhythmia agents].
    Scholz H
    Z Kardiol; 1996; 85 Suppl 6():91-6. PubMed ID: 9064988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sotalol: An important new antiarrhythmic.
    Anderson JL; Prystowsky EN
    Am Heart J; 1999 Mar; 137(3):388-409. PubMed ID: 10047618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New anti-arrhythmia agents].
    Honerjäger P; Schmidt G
    Z Kardiol; 1992; 81 Suppl 4():133-7. PubMed ID: 1363260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug therapy of ventricular tachycardia].
    Gonska BD
    Z Kardiol; 2000; 89 Suppl 10():51-7; discussion 57-8. PubMed ID: 11151775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is primary antiarrhythmic drug therapy for ventricular arrhythmias obsolete?
    Cooley R; Akhtar M; Sra J
    Curr Cardiol Rep; 1999 Nov; 1(4):268-73. PubMed ID: 10980853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infarct related artery patency: relation to serial electropharmacological studies and outcome in patients with previous myocardial infarction and ventricular tachyarrhythmias.
    Hoppe UC; Haverkamp W; Breithardt G; Borggrefe M
    Pacing Clin Electrophysiol; 2000 May; 23(5):854-62. PubMed ID: 10833706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The amiodarone-beta blockers combination could represent an alternative treatment in patients at risk for sudden death in which a benefit from implantable defibrillators has not been clearly demonstrated].
    Alboni P
    Ital Heart J Suppl; 2002 Mar; 3(3):337-43. PubMed ID: 12040849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metoprolol versus sotalol in the treatment of sustained ventricular tachycardia.
    Antz M; Cappato R; Kuck KH
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):627-35. PubMed ID: 8569226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-blockers for ventricular arrhythmias: have we underestimated their value?
    Campbell TJ
    Aust N Z J Med; 1996 Oct; 26(5):689-96. PubMed ID: 8958366
    [No Abstract]   [Full Text] [Related]  

  • 13. Class III antiarrhythmic drugs.
    Singh BN; Ahmed R
    Curr Opin Cardiol; 1994 Jan; 9(1):12-22. PubMed ID: 8199363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A perspective on the ESVEM trial current knowledge: sotalol should not be the first-line agent in the management of ventricular arrhythmias.
    Garan H
    Prog Cardiovasc Dis; 1996; 38(6):455-6. PubMed ID: 8638026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of patients with life-threatening sustained ventricular tachyarrhythmias--the role of guided antiarrhythmic drug therapy.
    Steinbeck G; Greene HL
    Prog Cardiovasc Dis; 1996; 38(6):419-28. PubMed ID: 8638023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of metoprolol and d,l-sotalol on microvolt-level T-wave alternans. Results of a prospective, double-blind, randomized study.
    Klingenheben T; Grönefeld G; Li YG; Hohnloser SH
    J Am Coll Cardiol; 2001 Dec; 38(7):2013-9. PubMed ID: 11738309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of sustained ventricular tachyarrhythmias: a comparison of d,l-sotalol with no antiarrhythmic drug treatment.
    Kühlkamp V; Mewis C; Mermi J; Bosch RF; Seipel L
    J Am Coll Cardiol; 1999 Jan; 33(1):46-52. PubMed ID: 9935007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive therapy for recurrent ventricular tachycardia in patients with implantable cardioverter defibrillators.
    Reiffel JA
    Curr Cardiol Rep; 2007 Sep; 9(5):381-6. PubMed ID: 17877933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological therapy for ventricular arrhythmias: evidence for current treatment strategies and perspectives for the future].
    Wegener FT; Grönefeld GC; Duray G; Ehrlich JR; Hohnloser SH
    Internist (Berl); 2006 Mar; 47(3):297-304, 306-7. PubMed ID: 16418866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
    Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
    Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.